Evidence for direct HIF-1α binding to the TFRC or FTH1 promoters has primarily been demonstrated in intestinal or inflammation-related models, rather than CRC-specific ChIP-seq studies. This evidence concerns the gene HIF1A and colorectal carcinoma.